<HashMap><database>biostudies-literature</database><scores/><additional><submitter>You HJ</submitter><funding>National Cancer Center</funding><funding>National Research Foundation of Korea</funding><pagination>1404</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8533394</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(10)</volume><pubmed_abstract>Androgen signaling via the androgen receptor (AR) is involved in normal prostate development and prostate cancer progression. In addition to androgen binding, a variety of protein kinases, including cyclic AMP-dependent protein kinase A (PKA), can activate the AR. Although hormone deprivation, especially that of androgen, continues to be an important strategy for treating prostate cancer patients, the disease ultimately progresses to castration-resistant prostate cancer (CRPC), despite a continuous hormone-deprived environment. To date, it remains unclear which pathways in this progression are active and targetable. Here, we performed a proteomic analysis of VCaP cells stimulated with androgen or forskolin to identify proteins specific for androgen-induced and androgen-bypassing signaling,</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Characterization of Proteins Regulated by Androgen and Protein Kinase a Signaling in VCaP Prostate Cancer Cells.</pubmed_title><pmcid>PMC8533394</pmcid><funding_grant_id>NCC-2110521</funding_grant_id><funding_grant_id>2015R1C1A1A02036315, 2018R1A2B6001241, and 2021R1A2C2014147</funding_grant_id><pubmed_authors>Song BS</pubmed_authors><pubmed_authors>You HJ</pubmed_authors><pubmed_authors>You BC</pubmed_authors><pubmed_authors>Kim JK</pubmed_authors><pubmed_authors>Park JM</pubmed_authors><pubmed_authors>Myung JK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of Proteins Regulated by Androgen and Protein Kinase a Signaling in VCaP Prostate Cancer Cells.</name><description>Androgen signaling via the androgen receptor (AR) is involved in normal prostate development and prostate cancer progression. In addition to androgen binding, a variety of protein kinases, including cyclic AMP-dependent protein kinase A (PKA), can activate the AR. Although hormone deprivation, especially that of androgen, continues to be an important strategy for treating prostate cancer patients, the disease ultimately progresses to castration-resistant prostate cancer (CRPC), despite a continuous hormone-deprived environment. To date, it remains unclear which pathways in this progression are active and targetable. Here, we performed a proteomic analysis of VCaP cells stimulated with androgen or forskolin to identify proteins specific for androgen-induced and androgen-bypassing signaling,</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-05T13:58:30.472Z</modification><creation>2025-04-05T13:58:30.472Z</creation></dates><accession>S-EPMC8533394</accession><cross_references><pubmed>34680521</pubmed><doi>10.3390/biomedicines9101404</doi></cross_references></HashMap>